Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 277-286

  Winter, J N ^a   Lazarus, H M ^a   Rademaker, A ^a   Villa, M ^a   Mangan, C ^a   Tallman, M ^a   Jahnke, L ^a   Gordon, L ^a   Newman, S ^a   Byrd, K ^a   Cooper, B W ^a   Horvath, N ^a   Crum, E ^a   Stadtmauer, E A ^a   Conklin, E ^a   Bauman, A ^a   Martin, J ^a   Goolsby, C ^a   Gerson, S L ^a   Bender, J ^a   O'Gorman, M ^a   more..

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BONE PAIN; BREAST CANCER; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG MONITORING; DRUG SAFETY; FEMALE; FEVER; HEMATOPOIESIS; HODGKIN DISEASE; HUMAN; MALE; MULTIPLE MYELOMA; MYALGIA; NAUSEA; NONHODGKIN LYMPHOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 9044248242     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.277     Document Type: Article

References (28)

1. McCredie KB, Hersh EM, Freireich EJ: Cells capable of colony formation in the peripheral blood of man. Science 171:293-294, 1971
2. Zwann FE: Haemopoietic progenitor cells in peripheral blood. Blut 45:87-95, 1982
3. Lasky LC, Ash RC, Kersey JH, et al: Collection of pluripotential hematopoietic stem cells by cytapheresis. Blood 59:822-827, 1982
4. Kessinger A, Armitage JO, Landmark JD, et al: Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 71:723-727, 1988
5. Sheridan WP, Begley CG, To LB, et al: Phase II study of autologous filgrastin (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marow Transplant 14:105-111, 1994
6. Socinski MA, Cannistra SA, Elias A, et al: Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1:1194-1198, 1988
7. Duhrsen U, Villeval JL, Boyd J, et al: Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72:2074-2081, 1988
8. Sheridan WP, Begley CG, Juttner CA, et al: Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose therapy. Lancet 1:640-644, 1992
9. Chao NJ, Schriber JR, Grimes K, et al: Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031-2035, 1993
10. Bishop MR, Anderson JR, Jackson JD, et al: High-dose therapy and peripheral blood progenitor cell transplantation: Effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood 83:610-616, 1994
11. Peters WP, Rosner G, Ross M, et al: Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 81:1709-1719, 1993
12. Richman CM, Weiner RS, Yankee RA: Increase in circulating stem cells following chemotherapy in man. Blood 47:1031-1039, 1976
13. To LB, Haylock DN, Kimber RJ, et al: High levels of circulating haemopoietic stem cells in very early remission from acute nonlymphoblastic leukaemia and their collection and cryopreservation. Br J Haematol 58:399-410, 1984
14. Jahnke L, Byrd K, Tallman M, et al: Mobilization of peripheral blood progenitor cells (PBPC) by cyclophosphamide (CYCLO) and/or growth factors: A comparison. Proc Am Soc Clin Oncol 13:578, 1994 (abstr)
15. Hogge DE, Cashman JD, Humphries RK, et al: Differential and synergistic effects of human granulocyte-macrophage colony-stimulating factor and human granulocyte colony-stimulating factor on hematopoiesis in human long-term marrow cultures. Blood 77:493-499, 1991
16. McNiece I, Andrews R, Stewart M, et al: Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: Synergistic interaction of GM-CSF pluse G-CSF. Blood 74:110-114, 1989
17. Haas R, Mohle R, Fuhauf S, et al: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787-3794, 1994
18. Sutherland HJ, Eaves AC, Eaves CJ: Quantitative assays for human hemopoietic progenitor cells, in: Gee AP (ed): Bone Marrow Processing and Purging: A Practical Guide. Boca Raton, FL, CRC, 1991, pp 155-171
19. + cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bone Marrow Transplant 13:479-485, 1994
20. Bender JG, Unverzagt KL, Walker DE, et al: Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 77:2591-2596, 1991
21. Steel RGD, Torrie JH: Principles and Procedures of Statistics. New York, NY, McGraw-Hill, 1980, pp 137, 188, 196
22. SAS Institute Inc: SAS/STAT User's Guide, Version 6 (ed 4), vol 4. Cary, NC, SAS Institute, 1989, p 891
23. Nademanee A, Sniecinski I, Schmidt GM, et al: High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. J Clin Oncol 12:2176-2186, 1994
24. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74:1905-1914, 1989
25. Siena S, Bregni M, Brando B, et al: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400-409, 1991
26. Dorr RT: Clinical properties of yeast-derived versus Escherichia coli-derived granulocyte-macrophage colony-stimulating factor. Clin Therapeut 15:19-29, 1993
27. Pettengell R, Testa NG, Swindell R, et al: Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 82:2239-2248, 1993
28. Jones HM, Jones SA, Watts MJ, et al: Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J Clin Oncol 12:1693-1702, 1994